Inhibition of DMBA-initiated rat mammary tumour development by 1-o- hexyl-2,3,5-trimethylhydroquinone, phenylethyl isothiocyanate, and novel synthetic ascorbic acid derivatives

European Journal of Cancer Prevention

Volumn 7, Issue 2, 1998, Pages 153-159

  Futakuchi, M ^a   Hirose, M ^a   Miki, T ^b   Tanaka, H ^a   Ozaki, M ^a   Shirai, T ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b Nippon Hypox Laboratories Inc   (Japan)

Author keywords

Antioxidant; Chemoprevention; DMBA model; Mammary carcinogenesis

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; DIMETHYLBENZ[A]ANTHRACENE; HYDROQUINONE; ISOTHIOCYANIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BREAST TUMOR; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; DIETARY INTAKE; FEMALE; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR PROMOTION;

EID: 0031968067     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Fukushima S, Imaida K, Sakata T et al (1983). Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats. Cancer Res 43: 4454-7.
2. Fukushima S, Ogiso T, Kurata Y et al (1987a). Absence of promotion potential for calcium L-ascorbate, L-ascorbic dipalmitate, L-ascorbic stearate and erythrobic acid on rat urinary bladder carcinogenesis. Cancer Lett 35: 17-25.
3. Fukushima S, Sakata T, Tagawa Y et al (1987b). Different modifying response of butylated hydroxyanisole, butylated hydroxytoluene, and other antioxidants in N,N-dibutylnitrosamine esophagus and forestomach carcinogenesis of rats. Cancer Res 47: 2113-6.
4. Guo Z, Smith TJ, Wang E et al (1992). Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats. Carcinogenesis 13: 2205-10.
5. Hamilton SM, Teel RW (1994). Effects of isothiocyanates on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene by hamster and rat liver microsomes. Anticancer Res 14: 1089-94.
6. Hirose M, Akagi K, Hasegawa R et al (1993). Strong inhibition of 2-amino-6-methyldipyrido[1,2-a;3′,2′-d]imidazole-induced mutagenesis and hepatocarcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone. Jpn J Cancer Res 84: 481-4.
7. Hirose M, Masuda A, Inoue T et al (1986). Modification by antioxidants and p,p′-diaminodiphenylmethane of 7,12-dimethylbenz[a]anthracene-induced carcinogenesis of the mammary gland and ear duct in CD rats. Carcinogenesis 7: 1155-9.
8. Hirose M, Masuda A, Fukushima S et al (1988). Effects of subsequent antioxidant treatment on 7,12-dimethylbenz[a]anthracene-initiated carcinogenesis of the mammary gland, ear duct and forestomach in Sprague-Dawley rats. Carcinogenesis 9: 101-4.
9. Hirose M, Satoh T, Ito N (1994). A strong new antioxidant with potent chemopreventive activity against heterocyclic amine-induced mutagenesis and carcinogenesis: HTHQ. Drug News Perspectives 7: 167-70.
10. Hirose M, Akagi K, Hasegawa R et al (1995a). Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP)-induced mammary gland carcinogenesis by antioxidants in F344 female rats. Carcinogenesis 16: 217-21.
11. Hirose M, Hasegawa R, Kimura J et al (1995b). Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole (Glu-P-1 )-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). Carcinogenesis 16: 3049-55.
12. Hirose M, Iwata S, Ito E et al (1995e). Strong anti-mutagenic activity of the novel lipophilic antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone against heterocyclic amine-induced mutagenesis in the Ames assay and its effect on metabolic activation of 2-amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole (Glu-p-1). Carcinogenesis 16: 2227-32.
13. Imaida K, Fukushima S, Shirai T et al (1983). Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats. Carcinogenesis 4: 895-9.
14. Imaida K, Fukushima S, Shirai T et al (1984). Promoting activities of butylated hydroxyanisole, butylated hydroxytoluene and sodium L-ascorbate forestomach and urinary bladder carcinogenesis initiated with methylnitrosourea in F344 male rats. Gann 75: 769-75.
15. Lin JM, Amin S, Trushin N et al (1993). Effects of isothiocyanates on tumorigenesis by benzo[a]pyrene in murine tumor models. Cancer Lett 74: 151-9.
16. Lubet RA, Steele VE, Eto I et al (1997). Chemopreventive efficacy of anethole trithione, N-acetyl-L-cysteine, miconazole and phenethylisothiocyanate in the DMBA-induced rat mammary cancer model. Int J Cancer 72: 95-101.
17. Masui T, Tsuda H, Inoue K et al (1986). Inhibitory effects of ethoxyquin, 4,4′-diaminodiphenylmethane and acetaminophen on rat hepatocarcinogenesis. Jpn J Cancer Res 77: 231-7.
18. Morse MA, Eklind KI, Amin SG et al (1992). Effect of frequency of isothiocyanate administration on inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenoma formation in A/J mice. Cancer Lett 62: 77-81.
19. Nihro Y, Miyataka H, Sudo T et al (1991a). 3-O-alkylascorbic acids as free-radical quenchers: synthesis and inhibitory effect on lipid peroxidation. J Med Chem 34: 2152-7.
20. Nihro Y, Sogawa S, Sudo T et al (1991b). 3-O-alkylascorbic acids as free radical quenchers. II. Inhibitory effects on some lipid peroxidation models. Chem Pharm Bull 39: 1731-5.
21. Nihro Y, Sogawa S, Izumi A et al (1992). 3-O-alkylascorbic acids as free radical quenchers. 3. Protective effect on coronary occlusion-reperfusion induced arrhythmias in anesthetized rats. J Med Chem 35: 1618-23.
22. Nihro Y, Furukawa H, Sogawa S et al (1994). Synthesis and anti lipid-peroxidation activity of hydroquinone monoalkyl ethers. Chem Pharm Bull 42: 576-9.
23. Ogawa K. Futakuchi M, Hirose M et al (1998). Stage and organ dependent effects of 1-O hexyl-2,3,5-trimethylhydroquinone, ascorbic acid derivatives, n-hepta decane-8, 10-dione and phenylethyl isothiocyanate in a rat multi-organ carcinogenesis model. Int J Cancer (in press).
24. Ramesha A, Rao N, Rao AR et al (1990). Chemoprevention of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in rat by the combined actions of selenium, magnesium, ascorbic acid and retinyl acetate. Jpn J Cancer Res 81: 1239-46.
25. Rao CV, Rivenson A, Kelloff GJ et al (1995). Chemoprevention of azoxymethane-induced colon cancer by ascorbylpalmitate, carbenoxolone, dimethylfumarate and p-methoxyphenol in male F344 rats. Anticancer Res 15: 1199-204.
26. Reddy BS, Hirota N, Katayama S (1982). Effect of dietary sodium ascorbate on 1,2-dimethylhydrazine-or methylnitrosourea-induced colon carcinogenesis in rats. Carcinogenesis 3: 1097-9.
27. Schwartz J, Shuklar G, Trickler D (1993). Vitamin C enhances the development of carcinomas in the hamster buccal pouch experimental model. Oral Surg Oral Med Oral Pathol 76: 718-22.
28. Shirai T, Fukushim S, Ohshima M et al (1984). Effects of butylated hydroxyanisole, butylated hydroxytoluene and NaCl on gastric carcinogenesis initiated with N-methyl-N′-nitro-N-nitrosoguanidine in F344 rats. J Natl Cancer Inst 72: 1189-98.
29. Shirai T, Ikawa E, Hirose M et al (1985a). Modification by five antioxidants of 1,2-dimethylhydrazine-initiated colon carcinogenesis in F344 rats. Carcinogenesis 6: 637-9.
30. Shirai T, Masuda A, Fukushima S et al (1985b). Effects of sodium L-ascorbate and related compounds on rat stomach carcinogenesis initiated by N-methyl-N′-nitro-N-nitrosoguanidine. Cancer Lett 29: 283-8.
31. Siglin JC, Barch DH, Stoner GD (1995). Effects of dietary phenethyl isothiocyanate, ellagic acid, sulindac and calcium on the induction and progression of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Carcinogenesis 16: 1101-6.
32. Smith TJ, Guo Z, Li C et al (1993). Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate. Cancer Res 53: 3276-82.
33. Takahashi M, Furukawa F, Toyoda K et al (1986). Effects of four antioxidants on N-methyl-N′-nitro-N-nitrosoguanidine initiated gastric tumor development in rats. Cancer Lett 30: 161-8.
34. Thamavit W, Tatematsu M. Ogiso T et al (1985). Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxygquin in induction of foci of rat liver cells containing the placental form of glutathione S-transferase. Cancer Lett 27: 295-303.
35. Tsuda H, Sakata T, Shirai T et al (1984). Modification of N-methyl-N-nitrosourea initiated carcinogenesis in the rat by subsequent treatment with antioxidants, phenobarbital and ethinyl estradiol. Cancer Lett 24: 19-27.
36. Wattenberg LW (1992). Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 52: 2085-91.
37. Werts ED, Gould MN (1986). Relationship between cellular superoxide dismutase and susceptibility to chemically induced cancer in the rat mammary gland. Carcinogenesis 7: 1197-201.
38. Wilkinson JT, Morse MA, Kresty LA et al (1995). Effect of alkyl chain length on inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis and DNA methylation by isothiocyanates. Carcinogenesis 16: 1011-5.